· rebuilt nightly from public records
Signal Sheet
Model Oncology is a private health care company in Bellaire, Texas, founded 2024. It raised $10.9M in Oct 2026, has 4 open roles including a Director, Pharmacy Business and its filings name 10 officers. Everything below links to the record it came from.
Open roles on the company's own careers page, read nightly.
HiringEquity raise reported to the SEC, Oct 2026.
CapitalPick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.
Want this matched to what you sell? Get early access to Pursuit Plans →The most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 15, 2026 | 4 open roles, 1 in leadership | Hiring | Careers page |
| Oct 15, 2026 | Posted a Director, Pharmacy Business opening | Hiring | Careers page |
| Oct 1, 2026 | Raised $10.9M in equity from 30 investors | Capital | SEC filing |
| Dec 20, 2024 | Raised $15M in equity from 6 investors | Capital | SEC filing |
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Jr. Thomas J. Harper | SEC filing, Oct 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | David S. Chernow | SEC filing, Oct 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Phillip H. Watts | SEC filing, Oct 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Steven Cutler | SEC filing, Oct 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Thomas J. Harper | SEC filing, Dec 2024 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Robert A. Ortenzio | SEC filing, Oct 2026 | Technology and tooling decisions |
| Chief Technology Officer | Martin F. Jackson | SEC filing, Oct 2026 | Technology and tooling decisions |
| Chief Technology Officer | William B. Downey | SEC filing, Oct 2026 | Technology and tooling decisions |
| Chief Technology Officer | MD Stanley M. Marks | SEC filing, Oct 2026 | Technology and tooling decisions |
| Chief Technology Officer | Max Buetow | SEC filing, Oct 2026 | Technology and tooling decisions |
| Director, Pharmacy Business | Hiring posted Oct 15, 2026 | Careers page | Technology and tooling decisions |
Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.
Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.
Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.
Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.
Every address Lakewave gives you is checked against Model Oncology's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.
Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.
Try it on Model Oncology with a free trial →| Headquarters | Bellaire, Texas, per the filing address |
| Industry group | Other Health Care |
| Founded | 2024, DELAWARE |
| Ownership | Private company |
| Raise history | $15M (Dec 2024) · $10.9M (Oct 2026) |
| Lakewave Rising | 42 · 2 kinds of evidence · rank in Texas after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Model Oncology reported a $10.9M equity raise to the SEC on Oct 1, 2026 with 30 investors.
The company's SEC filing, Oct 2026 names Jr. Thomas J. Harper (Executive Officer) among its officers.
Yes. 4 roles were open on its careers page on Nov 10, 2026, including a Director, Pharmacy Business posted Oct 15, 2026.
Bellaire, Texas, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialEvery account you select comes back scored by what changed this month, with the source for each fact.
Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.
Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.
A weekly note on what changed across your targets, so no account moves without you knowing.
Free trial · No credit card · Built from public records, refreshed nightly
Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.